Previous close | 26.45 |
Open | 26.45 |
Bid | 10.49 x 800 |
Ask | 36.27 x 900 |
Day's range | 26.00 - 26.72 |
52-week range | 23.00 - 36.30 |
Volume | |
Avg. volume | 396,833 |
Market cap | 7.275B |
Beta (5Y monthly) | 0.70 |
PE ratio (TTM) | 45.20 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 0.06 (0.23%) |
Ex-dividend date | 07 June 2023 |
1y target est | N/A |
PIOMBINO DESE, Italy, May 01, 2024--Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, announced today that it will participate in the Bank of America Securities Healthcare Conference taking place from Tuesday, May 14, 2024 to Thursday, May 16, 2024.
PIOMBINO DESE, Italy, April 25, 2024--Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, announced today that it will issue financial results for the first quarter of 2024 on Thursday, May 9, 2024, at 6:30 a.m. (ET).
PIOMBINO DESE, Italy, April 04, 2024--Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life science industries, today announced the appointment of Ugo Gay as its new Chief Operations Officer (COO).